Teponi (Tepotinib) 225mg*60 | TLPH Laos Generic | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Делиться
Product description

Generic Information: Teponi (Tepotinib) 225mg — Laos

Teponi is a Lao-manufactured generic of tepotinib, produced by Trans Continental Life Science & Pharmaceuticals (TLPH), a pharmaceutical manufacturer based in Laos. The product is supplied as 225 mg film-coated tablets in 60-tablet bottles, matching the originator's standard strength and pack size. TLPH is among the Lao manufacturers building a portfolio of affordable oncology generics for regional patients who cannot access branded targeted therapies, and Teponi is its tepotinib offering for MET exon 14-mutated NSCLC.

The abbreviation "TLPH" appears on packaging and trade documents, so buyers should recognise both the full company name and the short form when verifying a batch. At the standard 450 mg daily dose — two 225 mg tablets — one bottle of Teponi covers a 30-day month.

What Is Teponi Used For?

Teponi is used for metastatic non-small cell lung cancer carrying the MET exon 14 skipping mutation. This rare driver alteration is identified by molecular testing, and tepotinib is one of the targeted therapies developed specifically for it. Teponi is intended for adults whose disease carries the mutation, including those who have received prior treatment.

How Does Teponi Work?

The tepotinib in Teponi selectively inhibits the MET receptor tyrosine kinase. In tumours with MET exon 14 skipping, the MET receptor is left continuously active because its normal degradation signal is absent, driving unchecked cell growth. Teponi blocks this overactive kinase, slowing tumour progression with a targeted rather than broadly toxic mechanism.

Indications

  • Metastatic non-small cell lung cancer with MET exon 14 skipping mutation, confirmed by a validated test.
  • Adult patients in first-line or later lines of therapy.

Dosage and Administration

Take 450 mg once daily — two 225 mg tablets together — with or without food, swallowed whole. Do not crush or split the tablets. A 60-tablet bottle provides 30 days of therapy. The physician may modify or hold dosing based on oedema, liver function tests or other side effects, and treatment continues while benefit persists.

Side Effects

Common reactions include peripheral oedema, nausea, diarrhoea, fatigue and decreased appetite. Liver enzyme elevations require periodic monitoring. Serious but uncommon risks include interstitial lung disease and QT prolongation; patients should report new breathlessness, cough, palpitations or marked swelling promptly.

Storage

Store Teponi below 30°C in the original bottle, in a dry place, out of the reach of children. Use before the expiry date.

Why Choose the GLT?

GLT verifies each Teponi batch against the manufacturer's documentation and provides a transparent, traceable supply route for Lao generics. Lao-made tepotinib is typically several times cheaper than the branded originator in Western markets, which makes long-term MET-targeted treatment far more affordable for patients and institutions. We provide clear purchase documentation and direct, responsive support throughout ordering and delivery.

How to Order Teponi from GLT

Message GLT on WhatsApp at +86 15234153837 or email [email protected] to order Teponi 225 mg (60 tablets). Tell us your quantity, destination and order type, and we will confirm availability, batch details and shipping terms before dispatch.

FAQ

What does TLPH stand for? TLPH stands for Trans Continental Life Science & Pharmaceuticals, the Lao manufacturer of Teponi.

Is Teponi the same as Tepmetko? Teponi contains the same active ingredient (tepotinib) and dose as Tepmetko, manufactured in Laos by TLPH.

Where can I order Teponi? GLT can supply Teponi internationally; contact us on WhatsApp or email for availability.

Related Oncology Products

Tirzema (Тирзепатид) 2,5/5/7,5мг/0,5мл одноразовая шприц-ручка | Incepta (Бангладеш) | GLT

Tirzema — одноразовая шприц-ручка тирзепатида Incepta Pharmaceuticals, три официальные дозировки (2,5/5/7,5мг/0,5мл) для СД2 и контроля...

Barinat (Барицитиниб) 4мг | Дженерик-ингибитор JAK1/JAK2 | Natco Pharma Limited | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Natco Pharma Limited (Индия) — доступная альтернатива Olumiant при ревматоидном...

AVATODX (Аватромбопаг) 20мг*30 таб. | Bigbear Pharmaceutical (Лаос) | GLT

AVATODX — аватромбопаг 20 мг от Bigbear Pharmaceutical (Lao) Co., Ltd., лаосский рег. № 06L0985/23,...

KangQuXin 康曲欣 (Аватромбопаг) 20 мг × 10 таблеток | Beijing Continent (Gyre) | GLT

KangQuXin — аватромбопаг от Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), Китай

Baricent (Барицитиниб) 2мг | Дженерик-ингибитор JAK1/JAK2 | Incepta Pharmaceuticals Ltd. | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Incepta Pharmaceuticals Ltd. (Бангладеш) — доступная альтернатива Olumiant при ревматоидном...

Орфорглипрон (OriYo) 0,8–17,2 мг таблетки | Бангладешский дженерик пероральный GLP-1 | GLT

Дженерик орфорглипрона от National Drug Co. (Бангладеш), 6-ступенчатая титрация для контроля веса

Olumiant (Барицитиниб) таблетки 2мг/4мг | Ингибитор JAK1/JAK2 | Eli Lilly (США) | GLT

Селективный ингибитор JAK1/JAK2 компании Eli Lilly для лечения ревматоидного артрита, атопического дерматита и тяжёлой очаговой...

Zepbound (Тирзепатид) 2,5–15мг/0,5мл одноразовая шприц-ручка | Eli Lilly (США) | GLT

Zepbound — одноразовая шприц-ручка тирзепатида Eli Lilly, шесть дозировок для США (2,5–15мг/0,5мл) для хронического контроля...